JPL group believes in its strong commitment towards society and has been actively engaged with state health departments across various states in offering complimentary first aid kits etc. JPL believes in3 A's of Healthcare delivery -Affordability, Accessibility and Assurance
Cervical cancer has emerged as the second most common causes of cancer in Indian females; breast cancer being the top most. Every year around 6,00,000 females are detected with cervical cancer worldwide out of which 1,50,000 females are from India only (25% of the annual incidences of cervical cancer in the world is contributed by India). Due to late detection of cervical cancer, the mortality rates are very high. Around 2,65,000 females die annually due to cervical cancer worldwide with Indian females accounting for approx. 70,000 deaths (25% of the annual deaths of cervical cancer in the world is accounted by Indian females). The above data sadly implies that an Indian female dies every eight minutes due to cervical cancer. In order to contain incidences of this life threatening disease, it is critical that there is an early and timely detection of this dreadful cancer.
It is believed that screening services that detect pre-cancerous lesions in the cervix may be inaccessible to women due to high cost, shortage of equipment and providers, and less knowledge about service options.
Cervical cancer screening using Liquid Based Cytology is an advanced but expensive technology (currently charged at Rs 2,500 per screening), which offers higher accuracy as compared to historically used conventional pap smear technology.
On the back of its strong team of doctors, extensive network of centres along with a world class infrastructure, we believe that JPL is uniquely positioned to offer cervical cancer screening across the country. In order to address the key issues of higher cost, unavailability of skilled professionals and lack of awareness regarding cervical cancer, we are keen to launch an ambitious project titled “SAVE MAA” offering pan India free cervical cancer screening using Liquid Based Cytology across all the district hospitals in India.
As part of this project, we seek support from the district hospitals to create awareness about cervical cancer screening and ensure timely collection and delivery of specimens to our apex centre for their further processing and reporting.
JPL is in the process of tying up with the various state health departments to empanel it as its partner offering free cervical cancer screening across all the district hospitals.
Dr V SundarM.Ch (neuro) is an eminent Neuro Surgeon of Tamilnadu. Dr V Sundar was former Head of Institute of Neurology at Madras Medical College, Chennai and Former Senior Consultant at Govt Multi Speciality Hospital, Omandura Govt Estate Chennai. He is the President of Neuro Trauma society of India (2016-2018) . His extensive experience of over 35 years in the field of NeuroSurgery in particular and health care in general ensure world class quality at affordable cost . His guidance remains an asset to both Aanjan Path Labs and Jerath Path Labs.
Mrs Bakiyavathi Sundar holds a post graduate degree in Public Administration. She has been consistently contributing to the betterment of the society through various social assignments. She was the secretary of Guild of Service, Thanjavur and Chairman Juvenile Justice Board, Thanjavur. She had also served as the Non- Judicial Member of the State Consumer Disputes Redressal Commission, Chennai. Her passion to offer affordable healthcare to masses led her to venture into affordable diagnostic segment through Aanjan Path Labs. She is currently the Chairman of Aanjan Path Labs and is responsible for the entire functioning and operations of the company. She is very keen in providing the services at utmost care assuring smooth operations and development for the franchisees
Dr. Harsh Mohan is a Former Professor and Head of the Pathology Department, Government Medical College & Hospital, Chandigarh having superannuated in July 2015. He has an illustrious track record as an academician with a professional experience of 40 years. He has been a lead author of six textbooks of pathology in India and has been credited with more than 300 international and national scientific publications.
He has been the President of the Indian Association of Pathologists and Microbiologists, former Editor-in-Chief of the Indian Journal of Pathology and Microbiology and has been conferred several awards for contributing in the field of pathology.
Dr. Prashant Jerath completed his MD in Pathology from Government Medical College & Hospital, Sector 32, Chandigarh. He started his professional career as head of the Immunology and Cancer Department at Oswal Cancer Hospital, Ludhiana.
Owing to his strong passion towards providing better and affordable healthcare facilities to a relatively resource starved Indian population, Dr Prashant always believed that diagnostic industry is going to be one of the key focus areas in the healthcare industry in future. He realized that a lot of strain on the Indian healthcare industry could be eased out by improving the level of diagnostic facilities and this led to the genesis of India’s largest chain of allergy testing.
